SCLX
SCLX clinical trials: Scilex Holding Co
Every trial on ClinicalTrials.gov where Scilex Holding Co is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 18
- Trials linked
- 15
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
SCLX on the catalyst calendar · SCLX registry changes
- Primary completion May 30, 2023ActualPhase 2NCT05096494Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back PainScilex Pharmaceuticals, Inc. · Moderate to Severe Acute Lower Back PainCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 25, 2016ActualPhase 1NCT04150536Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and ExerciseScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 24, 2014ActualPhase 1NCT04144192Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy SubjectsScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 9, 2018ActualPhase 1NCT04319926Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human SubjectsScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 20, 2021ActualPhase 3NCT03372161Corticosteroid Lumbar Epidural Analgesia for RadiculopathyScilex Pharmaceuticals, Inc. · Lumbosacral Radicular PainCompletedSCLXLeadSMNRCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 24, 2022ActualPhase 1NCT05002946Pharmacokinetics of SP-104Scilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 20, 2021ActualPhase 1NCT04958876Study to Evaluate the Safety of SP-104Scilex Pharmaceuticals, Inc. · Healthy VolunteersCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 21, 2021ActualPhase 1NCT05106400Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing PatchesScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 27, 2019ActualPhase 1NCT04819581Pharmacokinetic Study of SP-103 in Healthy Adult Human SubjectsScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2019ActualPhase 1NCT04784728Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water ExposureScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 22, 2017ActualPhase 1NCT04320173Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medicated Plaster 5% in...Scilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 1NCT04312750Adhesion of Lidocaine Topical System 1.8%Scilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 27, 2016ActualPhase 1NCT04149938Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Healthy SubjectsScilex Pharmaceuticals, Inc. · HealthyCompletedSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT00495443Enhanced Safety Aesthetic Laser SystemScilex Ltd. · HirsutismUnknown statusSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredNo phase registeredNCT00441948Enhanced Safety Laser Hair Removal SystemScilex Ltd. · HirsutismUnknown statusSCLXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2, 2023ActualNo phase registeredNCT04378959Lidocaine Patch for Neck PainJohns Hopkins University · Neck PainCompletedSCLXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 7, 2023ActualPhase 4NCT04245371Lidocaine Patch 1.8% for Moderate to Severe Pain From Carpal Tunnel SyndromeJohn Papakonstantinou, MD · Carpal Tunnel SyndromeCompletedSCLXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 15, 2019ActualPhase 2NCT03613662A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102Semnur Pharmaceuticals, Inc. · Lumbosacral Radicular PainCompletedSMNRLeadSCLXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 18 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner